1. Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
   Sebastien Taurin et al, 2022, Medical Oncology CrossRef
2. Preparation of Liposomal Raloxifene-Graphene Nanosheet and Evaluation of Its In Vitro Anticancer Effects
   Ahmed E. Altyar et al, 2022, Dose-Response CrossRef
3. The Efficient Activity of Glabridin and its Derivatives Against EGFRmediated Inhibition of Breast Cancer
   Arabinda Ghosh et al, 2024, Current Medicinal Chemistry CrossRef
4. Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme
   Khaled Greish et al, 2018, Journal of Drug Targeting CrossRef
5. A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
   Hayley Nehoff et al, 2015, Oncotarget CrossRef
6. The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells
   E F O'Donnell et al, 2014, Cell Death & Disease CrossRef
7. Fluorescent Quantum Dots (QDs): A Theranostic Tool for Breast Cancer Management
   Joga Singh et al, 2022, Biomedical Translational Research CrossRef
8. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer
   Amit S. Yadav et al, 2020, Nanoscale CrossRef
9. GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway
   Lu Yang et al, 2016, Oncology Reports CrossRef
10. Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor
    Khaled Greish et al, 2019, Journal of Drug Targeting CrossRef
11. Raloxifene Induces Autophagy-Dependent Cell Death in Breast Cancer Cells via the Activation of AMP-Activated Protein Kinase
    Dong Eun Kim et al, 2015, Molecules and Cells CrossRef
12. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease
    Khaled Greish et al, 2017, Clinical and Translational Medicine CrossRef
13. Cryoablation for the treatment of breast cancer: immunological implications and future perspectives. Utopia or reality?
    Francesca Galati et al, 2024, La radiologia medica CrossRef
14. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
    SEBASTIEN TAURIN et al, 2016, International Journal of Oncology CrossRef
15. Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
    Juliana Q. Reimão et al, 2014, PLoS Neglected Tropical Diseases CrossRef
16. Piperidine nucleus in the field of drug discovery
    Mennatallah Mahmoud Abdelshaheed et al, 2021, Future Journal of Pharmaceutical Sciences CrossRef
17. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
    Qiaonan Guo et al, 2022, Disease Markers CrossRef